Perspective Therapeutics, Inc. (CATX)
3.77
-0.11
(-2.84%)
USD |
NYAM |
May 12, 16:00
3.85
+0.08
(+2.12%)
Pre-Market: 09:09
Perspective Therapeutics Free Cash Flow : -107.53M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Plus Therapeutics, Inc. | -20.84M |
| AVITA Medical, Inc. | -32.88M |
| Twist Bioscience Corp. | -95.14M |
| Elutia, Inc. | -46.69M |
| TriSalus Life Sciences, Inc. | -18.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.47M |
| Cash from Investing (Quarterly) | -109.55M |
| Cash from Financing (Quarterly) | 164.36M |
| Free Cash Flow Per Share (Quarterly) | -0.3699 |
| Free Cash Flow to Equity (Quarterly) | -39.30M |
| Free Cash Flow to Firm (Quarterly) | -38.22M |
| Free Cash Flow Yield | -34.95% |